IGI licenses Nova Skin dermatologist sales duties to "major" drug company.
This article was originally published in The Rose Sheet
Executive Summary
IGI ACTIVEL SKIN CARE LINE TO BOW IN 1997 in the salon/esthetician market. IGI is working on the skin care line, which employs the company's patented Novasome lipid microvesicle technology, with San Jose, Calif.-based Image Enhancing Dermatology (IED), a physician group partnership that specializes in medical and cosmetic dermatology. IGI and IED announced their partnership Aug. 21 ("The Rose Sheet" Aug. 26, p. 6)
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.